Claims for Patent: 6,344,600

Summary for Patent: 6,344,600

Title:	Method for producing human hemoglobin proteins using plant cells
Abstract:	A method for producing human hemoglobin proteins by (i) inserting into plant cells one or more nucleic acid molecules that each comprise at least one sequence coding for a protein component of a human hemoglobin protein capable of reversibly binding oxygen, and optionally a sequence coding for a selection agent; (ii) selecting cells containing nucleic acid coding for the protein component of the human hemoglobin protein; (iii) optionally propagating the transformed cells either in a culture or by regenerating whole transgenic or chimeric plants; and (iv) recovering and optionally purifying the human hemoglobin protein that includes a complex consisting of the protein or proteins coded for by the nucleic acid and at least one iron-containing polphyritic nucleus, or a plurality of such complexes.
Inventor(s):	Merot; Bertrand (Volvic, FR), Dieryck; Wilfrid (Saint-Pathus, FR), Lenee; Philippe (Noumea, FR), Marden; Michael (Aulnay-sous-Bois, FR), Gruber; Veronique (Chamalieres, FR), Pagnier; Renee-Josee (Le Kremlin-Bicetre, FR), Baudino; Sylvie (Orcines, FR), Poyart; Claude (Paris, FR)
Assignee:	Meristem Therapeutics (Clermont-Ferrand, FR) Institut National de la Sante et de la Recherche Medicale (Paris Cedex, FR)
Application Number:	08/983,564
Patent Claims:	1. A method for producing human hemoglobin protein which reversibly binds oxygen comprising the following steps: i) transforming into plant cells one or more nucleic acid molecule(s) comprising sequences encoding the .alpha. and .beta. polypeptide chains of human hemoglobin; ii) propagating the transformed plant cells in culture or regenerating transgenic or chimeric plants from said transformed plant cells; and iii) recovering and purifying said human hemoglobin protein which reversibly binds oxygen, said recovering due to at least one association in the transformed plant cells of at least one polypeptide chain of .alpha. and .beta. human hemoglobin encoded by said nucleic acid molecules with at least one iron-containing porphyrin nucleus. 2. The method according to claim 1, wherein the sequences encoding the .alpha. and .beta. polypeptide chains are contained in the same nucleic acid molecule. 3. The method according to claim 1, wherein the sequences encoding the .alpha. and .beta. polypeptide chains are contained in separate nucleic acid molecules. 4. The method of claim 1, wherein the transforming comprises transforming the nuclear genome of the plant cells. 5. The method according to claim 1, wherein the nucleic acid molecules further comprise one or more sequence(s) encoding an N-terminal signal peptide, a signal that retains the protein in the endoplasmic reticulum, or a vacuolar homing signal. 6. The method according to claim 1, wherein the nucleic acid molecules further comprise sequences for regulation of transcription which are recognized by plant cells. 7. The method according to claim 1, wherein said method further comprises, between the propagating step and the recovering step, a step for detecting human hemoglobin protein. 8. The method according to claim 1, wherein said propagating step comprises adding iron-containing protoporphyrin IX to the culture medium to increase growth of the cells. 9. A recombinant nucleic acid comprising: i) one or more sequence(s) encoding an .alpha. or .beta. polypeptide chain of human hemoglobin protein which reversibly binds oxygen; ii) sequences for regulation of transcription which are recognized by a plant cell, comprising a promoter and sequences for regulation of termination, and iii) one or more sequence(s) encoding a targeting signal of plant origin. 10. The recombinant nucleic acid according to claim 9, wherein the promoter is of plant origin. 11. The recombinant nucleic acid according to claim 9, wherein the sequences encoding the targeting signal encode an N-terminal signal peptide of plant origin in combination with an endoplasmic retention signal or a vacuolar homing signal. 12. The recombinant nucleic acid according to claim 9, further comprising one or more intron(s) of plant origin. 13. The recombinant nucleic acid according to claim 9, wherein the sequences encoding the protein component are cDNA. 14. A vector comprising one or more nucleic acids according to claim 9. 15. Plant cells transformed in a stable manner with the nucleic acid according to claim 9. 16. The plant cells according to claim 15, wherein said plant cells are in a culture in liquid medium, are immobilized, or are in a root culture. 17. The plant cells according to claim 15, wherein said cells form part of a whole transformed plant. 18. A chimeric or transgenic plant that produces human hemoglobin protein, wherein said chimeric or transgenic plant comprises cells according to claim 15. 19. Seeds of the transgenic plant according to claim 18. 20. A method for producing human hemoglobin protein comprising the following steps: i) transforming plant cells with one or more nucleic acid molecule(s) comprising sequences encoding: the .alpha. polypeptide chain of human hemoglobin of SEQ ID NO:31, the .beta. polypeptide chain of human hemoglobin of SEQ ID NO:33, a variant of said .alpha. polypeptide chain of human hemoglobin wherein said variant is selected from the group consisting of an I variant of SEQ ID NO:31, a G.sub.Honolulu variant of SEQ ID NO:31, a Norfolk variant of SEQ ID NO:31, an M.sub.Boston variant of SEQ ID NO:31, a G.sub.Philadelphia variant of SEQ ID NO:31, and an O.sub.Indonesia variant of SEQ ID NO:31, or a variant of said .beta. polypeptide chain of human hemoglobin wherein said variant is selected from the group consisting of a C variant of SEQ ID NO:33, an S variant of SEQ ID NO:33, a G.sub.San Jose variant of SEQ ID NO:33, an E variant of SEQ ID NO:33, an M.sub.Saskatoon variant of SEQ ID NO:33, a Zurich variant of SEQ ID NO:33, an M.sub.Milwaukee variant of SEQ ID NO:33, a D.sub.Puniab variant of SEQ ID NO:33, a Mequon variant of SEQ ID NO:33, a Providence variant of SEQ ID NO:33, a variant of SEQ ID NO:33 wherein Phe-41 is replaced with Tyr and wherein Lys-82 is replaced with Asp, and a variant of SEQ ID NO:33 wherein Phe-41 is replaced with Tyr and wherein Lys-66 is replaced with Thr; ii) propagating the transformed plant cells in culture or regenerating whole transgenic or chimeric plants from said transformed plant cells; and iii) recovering and purifying a human hemoglobin protein comprising an assembly of the polypeptides encoded by said nucleic acid molecule(s). 21. A recombinant nucleic acid comprising: i) one or more sequence(s) encoding: the .alpha. polypeptide chain of human hemoglobin of SEQ ID NO:31, the .beta. polypeptide chain of human hemoglobin of SEQ ID NO:33, a variant of said .alpha. polypeptide chain of human hemoglobin wherein said variant is selected from the group consisting of an I variant of SEQ ID NO:31, a G.sub.Honolulu variant of SEQ ID NO:31, a Norfolk variant of SEQ ID NO:31, an M.sub.Boston variant of SEQ ID NO:31, a G.sub.Philadelplia variant of SEQ ID NO:31, and an O.sub.Indonesia variant of SEQ ID NO:31, or a variant of said .beta. polypeptide chain of human hemoglobin wherein said variant is selected from the group consisting of a C variant of SEQ ID NO:33, an S variant of SEQ ID NO:33, a G.sub.San Jose variant of SEQ ID NO:33, an E variant of SEQ ID NO:33, an M.sub.Saskatoon variant of SEQ ID NO:33, a Zurich variant of SEQ ID NO:33, an M.sub.Milwaukee variant of SEQ ID NO:33, a D.sub.Puniab variant of SEQ ID NO:33, a Mequon variant of SEQ ID NO:33, a Providence variant of SEQ ID NO:33, a variant of SEQ ID NO:33 wherein Phe-41 is replaced with Tyr and wherein Lys-82 is replaced with Asp, and a variant of SEQ ID NO:33 wherein Phe-41 is replaced with Tyr and wherein Lys-66 is replaced with Thr; ii) sequences for regulation of transcription which are recognized by a plant cell, comprising a promoter and sequences for regulation of termination, and iii) one or more sequence(s) encoding a homing signal of plant origin. 22. A method for producing human hemoglobin protein comprising the following step(s): i) introducing into plant cells, one or more nucleic acid molecule(s) comprising sequences encoding: the .alpha. polypeptide chain of human hemoglobin of SEQ ID NO:31, the .beta. polypeptide chain of human hemoglobin of SEQ ID NO:33, a variant of said .alpha. polypeptide chain of human hemoglobin wherein said variant has a substitution selected from the group consisting of: Lys 16 Glu Glu 30 Gln Gly 57 Asp His 58 Tyr Asn 68 Lys and Glu 116 Lys, a variant of said .beta. polypeptide chain of human hemoglobin wherein said variant has a substitution selected from the group consisting of: Glu 6 Lys Glu 6 Val Glu 7 Gly Glu 26 Lys His 63 Tyr His 63 Arg Val 67 Glu Glu 121 Gln Phe 41 Tyr and Lys 82 Asp, a variant of SEQ ID NO:33 wherein Phe-41 is replaced with Tyr and wherein Lys-82 is replaced with Asp, or a variant of SEQ ID NO:33 wherein Phe-41 is replaced with Tyr and wherein Lys-66 is replaced with Thr; ii) propagating the transformed plant cells in culture or regenerating whole transgenic or chimeric plants from said transformed plant cells; and iii) recovering and purifying a human hemoglobin protein comprising an assembly of the polypeptides encoded by said nucleic acid molecule(s). 23. Recombinant nucleic acid comprising: i) one or more sequence(s) encoding: the .alpha. polypeptide chain of human hemoglobin of SEQ ID NO:31, the .beta. polypeptide chain of human hemoglobin of SEQ ID NO:33, a variant of said .alpha. polypeptide chain of human hemoglobin wherein said variant has a substitution selected from the group consisting of: Lys 16 Glu Glu 30 Gln Gly 57 Asp His 58 Tyr Asn 68 Lys and Glu 116 Lys, a variant of said .beta. polypeptide chain of human hemoglobin wherein said variant has a substitution selected from the group consisting of: Glu 6 Lys Glu 6 Val Glu 7 Gly Glu 26 Lys His 63 Tyr His 63 Arg Val 67 Glu Glu 121 Gln Phe 41 Tyr and Lys 82 Asp, a variant of SEQ ID NO:33 wherein Phe-41 is replaced with Tyr and wherein Lys-82 is replaced with Asp, or a variant of SEQ ID NO:33 wherein Phe-41 is replaced with Tyr and wherein Lys-66 is replaced with Thr; ii) sequences for regulation of transcription which are recognized by a plant cell, comprising a promoter and sequences for regulation of termination, and iii) one or more sequence(s) encoding a homing signal for plant origin.

Details for Patent 6,344,600

Applicant	Tradename	Biologic Ingredient	Dosage Form	BLA	Approval Date	Patent No.	Expiredate
Merck Sharp & Dohme Corp.	INTRON A	interferon alfa-2b	For Injection	103132	06/04/1986		2015-07-17
Merck Sharp & Dohme Corp.	INTRON A	interferon alfa-2b	For Injection	103132			2015-07-17
Merck Sharp & Dohme Corp.	INTRON A	interferon alfa-2b	Injection	103132			2015-07-17